Hint mode is switched on Switch off
For swift navigation between sections

Scandion Oncology
LEI 549300MPWDMQ5LZEGD09

PDF download

Choose all Reset all
Download Cancel
Organization name
Scandion Oncology AS
Country name
Denmark
Country of registration
Denmark
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Scandion Oncology AS operates as a biotechnology company. The Company discovers, develops, and commercializes drugs and medicines for the treatment of cancer. Scandion Oncology serves patients in Denmark.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300MPWDMQ5LZEGD09
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CVR-nummer
    38613391
Registration is required to get access.